๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Assessing disease risk in pediatric ulcerative colitis

โœ Scribed by Joel R. Rosh

Book ID
102267727
Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
43 KB
Volume
17
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Infliximab efficacy in pediatric ulcerat
Infliximab efficacy in pediatric ulcerative colitis
โœ Alexandra P Eidelwein; Carmen Cuffari; Vivian Abadom; Maria Oliva-Hemker ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 114 KB
Assessing disease activity in ulcerative
Assessing disease activity in ulcerative colitis: Patients or their physicians?
โœ Dan Turner; Anne M. Griffiths; David Mack; Anthony R. Otley; Cynthia H. Seow; A. ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 91 KB ๐Ÿ‘ 1 views

## Background: We aimed to determine the optimal approach to assess disease activity (i.e., biological inflammation) in ulcerative colitis (UC) by comparing patients' and physicians' rating of the disease. Methods: This was a prospective, multicenter, double-cohort study. The first cohort was com

Cancer risks in ulcerative colitis patie
Cancer risks in ulcerative colitis patients
โœ Kari Hemminki; Xinjun Li; Jan Sundquist; Kristina Sundquist ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 72 KB ๐Ÿ‘ 2 views

## Abstract Patients diagnosed with ulcerative colitis (UC) are known to be at an increased risk of colorectal and liver cancers and leukemia. UC is an autoimmune disease, which may present a wider spectrum of cancers. We wanted to examine the risk of cancer in a large population of UC patients in